Due to the current circumstances arising from the global COVID-19 pandemic and the resulting constraints experienced worldwide within clinical trials as well as pre-clinical research EMD Serono has decided to pause the Grant for Growth Innovation (GGI) for the 2021-2022 grant cycles and will not be accepting applications for the referred period. This decision does not affect the ongoing research projects for 2020.
Please refer back to this website for future updates.